News section

European Patent Office upholds decision to revoke Neem patent
Munich, Germany
March 8, 2005

Source: IFOAM

In a landmark decision today, the European Patent Office upheld a decision to revoke in its entirety a patent on a
fungicidal product derived from seeds of the Neem, a tree indigenous to the Indian subcontinent. The historic action resulted from a legal challenge mounted ten years ago by three Opponents: the renowned Indian environmentalist Vandana Shiva, Magda Aelvoet, then MEP and President of the Greens in the European Parliament, and the International Federation of Organic Agriculture Movements (IFOAM). Their joint Legal Opposition claimed that the fungicidal properties of the Neem tree had been public knowledge in India for many centuries and that this patent exemplified how international law was being misused to transfer biological wealth
from the South into the hands of a few corporations, scientists, and countries of the North. Today the EPO’s Technical Board of Appeals dismissed an Appeal by the would-be proprietors—the United States of America and the company Thermo Trilogy—and maintained the decision of its Opposition Division five years ago to revoke the Neem patent in its entirety, thus bringing to a close this ten-year battle in the world’s first legal challenge to a biopiracy patent.

Dr. Vandana Shiva, who travelled from India to be present at today’s hearing, commented, “What a lovely celebration for the women of India that this long-awaited decision falls on March 8th, International
Women’s Day. Denying the patent means upholding the value of traditional knowledge for millions of women not only in India, but throughout the South. The FREE TREE WILL STAY FREE. This victory is the result of extremely long solidarity. It is a victory of committed citizens over commercial interests and big powers.”

Magda Aelvoet, Belgian Minister of State and former Health and Environment Minister, was President of the Green Group in the European Parliament when the original Opposition was submitted. Just after the ruling, she commented, "Our victory against biopiracy is threefold. First, it is a victory for traditional knowledge and practices. This is the first time anybody has been able to have a patent rejected on these grounds. Second, it is a victory for solidarity: With the people of developing countries—who have definitively earned the sovereign rights to their natural resources—and and with our colleagues in the NGOs, who fought with us against this patent for the last ten years. And third, coming as it does on International Women's Day, this is also a victory for women. The three people who successfully argued this case against the might of the U.S. administration and its corporate allies, were women: Vandana Shiva, Linda Bullard and myself. It can also inspire and help people from developing countries who suffer the same kind of theft but did not think it was possible to combat it."

Linda Bullard, former President of the International Federation of Organic Agriculture Movements (IFOAM), stated, “We are deeply gratified that through our case the EPO has recognized the intellectual achievements of the South. We were able to establish that traditional knowledge systems can be a means of establishing “prior art” and thus used to destroy the claims of “novelty” and “inventiveness” in these biopiracy patents. This now becomes case law, but the historic precedent must be further developed and transposed into overall international
legal frameworks so that this type of theft is no longer possible.”

Although two days had been set aside to examine the Appeal, the case was so clear that the Technical Board of Appeals needed only two hours to reach a decision to dismiss the Appeal.

The Opponents were legally represented throughout the ten year battle by Prof. Dr. Fritz Dolder, Professor Intellectual Property with the Faculty of Law at the University of Basel, in Switzerland.* Dr. Dolder explained
that a reformulated claim submitted by the patent holders as part of their Appeal was rejected on formal grounds. Subsequently, the main body of the patent was tested with regard to novelty, disclosure, and inventive step…“and revoked irrevocably! This is the first time that the EPO has legally concluded a biopiracy case.”


Source: CORDIS News

EPO accepts biopiracy argument and revokes patent

The European Patent Office (EPO) has, for the first time, decided to withdraw a patent on the grounds of biopiracy.

A patent was awarded to the US Department of Agriculture and the multinational company WR Grace in 1995 for the fungicidal properties of seeds extracted from the neem tree, native to India. But a campaign for the revocation of the patent was immediately launched by a three-party coalition: the European Parliament's Green Party, India's Research Foundation for Science, Technology and Ecology, and the International Federation of Organic Agriculture Movements.

'[This] is a victory for traditional knowledge and practises. This is the first time anybody has been able to have a patent rejected on these grounds. Second, it is a victory for solidarity; with the people of developing countries - who have definitively earned the sovereign rights to their natural resources, and with our colleagues in the NGOs [non-governmental organisations] who fought with us against this patent for the last ten years,' said Magda Aelvoet, who was president of the Green Party in 1995, when the original submission to the EPO was made.

The patent was revoked five years after it was awarded, but the decision was appealed by the US Department of Agriculture and WR Grace. The decision on 8 March brings the ten-year dispute to a close.

'Biopiracy' describes a process in which living resources or traditional knowledge and practises are patented, thus applying intellectual property restrictions to their use. The resources in question are predominantly from developing countries, and are the subject of patent applications by companies in developed countries. The neem tree has been used for thousands of years in India in agriculture, public health, medicine, toiletries, cosmetics and livestock protection. A patent application should always be rejected if there is prior existing knowledge about a product.

News release

Other news from this source

11,587

Back to main news page

The news release or news item on this page is copyright © 2005 by the organization where it originated.
The content of the SeedQuest website is copyright © 1992-2005 by SeedQuest - All rights reserved
Fair Use Notice